Can anticoagulants reduce thromboembolism risk in patients with genetic polymorphisms affecting clotting factors, and what evidence supports this?
Gaurav ChauhanContributor
Can anticoagulants reduce the risk of thromboembolism in patients with genetic polymorphisms of clotting factors?
Share
Yes, anticoagulants can reduce thromboembolism risk in patients with genetic polymorphisms that affect clotting factors. Studies show they adjust the blood’s ability to clot, countering the increased risk from such genetic variations.